These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 21102481)

  • 21. The safety and efficacy of transarterial chemoembolization combined with sorafenib and sorafenib mono-therapy in patients with BCLC stage B/C hepatocellular carcinoma.
    Wu FX; Chen J; Bai T; Zhu SL; Yang TB; Qi LN; Zou L; Li ZH; Ye JZ; Li LQ
    BMC Cancer; 2017 Sep; 17(1):645. PubMed ID: 28899349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical observation of the treatment with combination of transcatheter arterial chemoembolization and sorafenib for hepatocellular carcinoma with lung metastasis].
    Duan F; Wang MQ; Liu FY; Wang ZJ; Song P
    Zhonghua Zhong Liu Za Zhi; 2009 Sep; 31(9):716-8. PubMed ID: 20021873
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination of transcatheter arterial chemoembolization and interrupted dosing sorafenib improves patient survival in early-intermediate stage hepatocellular carcinoma: A post hoc analysis of the START trial.
    Lee TY; Lin CC; Chen CY; Wang TE; Lo GH; Chang CS; Chao Y
    Medicine (Baltimore); 2017 Sep; 96(37):e7655. PubMed ID: 28906355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patterns of sorafenib and TACE treatment of unresectable hepatocellular carcinoma in a Chinese population: subgroup analysis of the GIDEON study.
    Liu F; Meng Z; Shao G; Wang J; Wang Z; Yang J; Yip CS; He D
    Mol Biol Rep; 2017 Feb; 44(1):149-158. PubMed ID: 27981445
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined endovascular brachytherapy, sorafenib, and transarterial chemobolization therapy for hepatocellular carcinoma patients with portal vein tumor thrombus.
    Zhang ZH; Liu QX; Zhang W; Ma JQ; Wang JH; Luo JJ; Liu LX; Yan ZP
    World J Gastroenterol; 2017 Nov; 23(43):7735-7745. PubMed ID: 29209114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the Efficacy of Sorafenib on Overall Survival in Patients with Hepatocellular Carcinoma using FT Rate: A Devised Index.
    Ohki T; Kondo M; Karasawa Y; Kawamura S; Maeshima S; Kojima K; Seki M; Toda N; Shioda Y; Tagawa K
    Adv Ther; 2017 May; 34(5):1097-1108. PubMed ID: 28389996
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of transcatheter arterial chemoembolization followed by sorafenib for intermediate/advanced hepatocellular carcinoma in patients in Japan: a retrospective analysis.
    Ohki T; Sato K; Yamagami M; Ito D; Yamada T; Kawanishi K; Kojima K; Seki M; Toda N; Tagawa K
    Clin Drug Investig; 2015 Nov; 35(11):751-9. PubMed ID: 26446004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination of TACE and Sorafenib Improves Outcomes in BCLC Stages B/C of Hepatocellular Carcinoma: A Single Centre Experience.
    Varghese J; Kedarisetty C; Venkataraman J; Srinivasan V; Deepashree T; Uthappa M; Ilankumaran K; Govil S; Reddy M; Rela M
    Ann Hepatol; 2017; 16(2):247-254. PubMed ID: 28233748
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sequential therapy of transarterial chemoembolisation and sorafenib in intermediate stage hepatocellular carcinoma.
    Welker MW; Zangos S; Kriener S; Mönch C; Zeuzem S; Trojan J
    J Gastrointest Cancer; 2010 Jun; 41(2):149-52. PubMed ID: 20396977
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and efficacy of transarterial chemoembolization plus sorafenib for hepatocellular carcinoma with portal venous tumour thrombus.
    Pan T; Li XS; Xie QK; Wang JP; Li W; Wu PH; Zhao M
    Clin Radiol; 2014 Dec; 69(12):e553-61. PubMed ID: 25304928
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Survival benefit of transarterial chemoembolization in patients with metastatic hepatocellular carcinoma: a single center experience.
    Bettinger D; Spode R; Glaser N; Buettner N; Boettler T; Neumann-Haefelin C; Brunner TB; Gkika E; Maruschke L; Thimme R; Schultheiss M
    BMC Gastroenterol; 2017 Aug; 17(1):98. PubMed ID: 28797231
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The analysis of the efficacy and safety of combined transarterial chemoembolization with sorafenib in patients with large hepatocellular carcinoma].
    Zhang YQ; Yang JY; Wang Y; Huang YH; Fan WZ; Li JP
    Zhonghua Yi Xue Za Zhi; 2013 Apr; 93(13):987-91. PubMed ID: 23886261
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early Sorafenib-related Biomarkers for Combination Treatment with Transarterial Chemoembolization and Sorafenib in Patients with Hepatocellular Carcinoma.
    Zhong BY; Ni CF; Chen L; Zhu HD; Teng GJ
    Radiology; 2017 Aug; 284(2):583-592. PubMed ID: 28263701
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early prediction of survival in hepatocellular carcinoma patients treated with transarterial chemoembolization plus sorafenib.
    Meng XC; Chen BH; Huang JJ; Huang WS; Cai MY; Zhou JW; Guo YJ; Zhu KS
    World J Gastroenterol; 2018 Jan; 24(4):484-493. PubMed ID: 29398869
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Concurrent sorafenib therapy extends the interval to subsequent TACE for patients with unresectable hepatocellular carcinoma.
    Yao X; Yan D; Zeng H; Liu D; Li H
    J Surg Oncol; 2016 May; 113(6):672-7. PubMed ID: 26989044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sorafenib enhances effects of transarterial chemoembolization for hepatocellular carcinoma: a systematic review and meta-analysis.
    Fu QH; Zhang Q; Bai XL; Hu QD; Su W; Chen YW; Su RG; Liang TB
    J Cancer Res Clin Oncol; 2014 Aug; 140(8):1429-40. PubMed ID: 24770582
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of transarterial chemoembolization in relation with sorafenib for patients with advanced hepatocellular carcinoma.
    Ha Y; Lee D; Shim JH; Lim YS; Lee HC; Chung YH; Lee YS; Park SR; Ryu MH; Ryoo BY; Kang YK; Kim KM
    Oncotarget; 2016 Nov; 7(45):74303-74313. PubMed ID: 27494871
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sorafenib in combination with transarterial chemoembolization in Chinese patients with hepatocellular carcinoma: a subgroup interim analysis of the START trial.
    Han G; Yang J; Shao G; Teng G; Wang M; Yang J; Liu Z; Feng G; Yang R; Lu L; Chao Y; Wang J
    Future Oncol; 2013 Mar; 9(3):403-10. PubMed ID: 23469975
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multimodal approaches to the treatment of hepatocellular carcinoma.
    Cabibbo G; Latteri F; Antonucci M; Craxì A
    Nat Clin Pract Gastroenterol Hepatol; 2009 Mar; 6(3):159-69. PubMed ID: 19190599
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comprehensive treatments for hepatocellular carcinoma with tumor thrombus in major portal vein.
    Ye HH; Ye JZ; Xie ZB; Peng YC; Chen J; Ma L; Bai T; Chen JZ; Lu Z; Qin HG; Xiang BD; Li LQ
    World J Gastroenterol; 2016 Apr; 22(13):3632-43. PubMed ID: 27053855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.